MILabs will launch G-SPECT, its new SPECT system that offers faster brain scanning speeds at a resolution of less than 3 mm. The preclinical imaging developer will present initial brain scans from G-SPECT at the SNMMI meeting this month in Baltimore.
A study published in Molecular Imaging and Biology supports the use of 4D microSPECT for evaluating murine cardiac function. MILabs' U-SPECT-II/CT offered some advantages over microCT, the company said, including better detection of areas of ischemia or infarction. MicroSPECT also eliminates the need for using several acquisition protocols and contrast agents as it can analyze cardiac function and distribution of multiple myocardial radiotracers at the same time.
MILabs has launched its Vector+ SPECT/PET molecular imaging system, which features novel exchangeable collimators and reconstruction methods. The system, to be showcased at next month's SNMMI Annual Meeting, can be combined with CT for an integrated SPECT/PET/CT platform.
MILabs has launched the U-SPECT Quick Start system, a molecular imaging technology intended for research. The company said the system is cost-effective and compatible with a dedicated or versatile high-performance collimator.
Carestream Molecular Imaging, a unit of Carestream Health, has entered into an exclusive, multi-year global deal with Spanish firm OncoVision concerning the sale, marketing and servicing of the Albira PET/SPECT/CT imaging system for use in small-animal research. The Albira system allows for fast acquisition and reconstruction of high-resolution PET and SPECT images.